Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Piqur Therapeutics AG
DescriptionMammalian target of rapamycin (mTOR; FRAP; RAFT1) inhibitor
Molecular Target Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today